RNA vaccines

US11020477B2 · kind B2 · utility

Assignee

• BIONTECH RNA PHARMACEUTICALS GMBH · DE

Inventors

• Josef Thalhamer · Salzburg, AT
• Richard Weiss · Salzburg, AT
• Elisabeth Rosler · Salzburg, AT
• Sandra Scheiblhofer · Salzburg, AT
• Angelika Fruhwirth · Innsbruck, AT

Key dates

• Filing date: Jan 20, 2017
• Grant date: Jun 1, 2021
• Expiry date: Jan 20, 2037

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2770/36143
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A RNA vaccine containing a RNA molecule encoding an allergen or derivative thereof, in which the allergen is an allergen of Alnus glutinosa, Alternaria alternata, Ambrosia artemisiifolia, Apium graveolens, Arachis hypogaea, Betula verrucosa, Carpinus betulus, Castanea sativa, Cladosporium herbarum, Corylus avellana, Cryptomeria japonica, Cyprinus carpio, Daucus carota, Dermatophagoides pteronyssinus, Fagus sylvatica, Felis domesticus, Hevea brasiliensis, Juniperus ashei, Malus domestica, Quercus alba or Phleum pratense.